IDO1 and metabolic dysfunction-associated steatotic liver disease: Patients classified as high-risk based on PLS-NAFLD showed an association with IDO1+ dendritic cells, dysfunctional CD8+ T cells in fibrotic portal tracts, and impaired metabolic regulators.